How effective is Prednisone for Multiple Sclerosis? (a real world drug study)
Summary:
Overall ratings: 2.9/5 Long term ratings: 2.3/5
This is a phase IV clinical study of how effective Prednisone (prednisone) is for Multiple sclerosis and for what kind of people. The study is created by eHealthMe from 9 Prednisone users and is updated continuously.
What is Prednisone?
Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. eHealthMe is studying from 636,824 Prednisone users. Check the latest studies of Prednisone.
What is Multiple sclerosis?
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,095 drugs and 1,358 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.
9 people are studied for taking Prednisone in Multiple sclerosis
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Prednisone effectiveness for Multiple sclerosis (number of people):
Overall:
- not at all: 1
- somewhat: 2
- moderate: 3
- high: 3
- very high: 0
Long Term:
- not at all: 1
- somewhat: 1
- moderate: 2
- high: 0
- very high: 0
Gender of people who take Prednisone for Multiple sclerosis *:
- female: 88.89 %
- male: 11.11 %
Age of people who take Prednisone for Multiple sclerosis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 22.22 %
- 30-39: 33.33 %
- 40-49: 11.11 %
- 50-59: 11.11 %
- 60+: 22.22 %
Who find Prednisone more effective for Multiple Sclerosis?
Gender of people who take Prednisone for Multiple sclerosis *:
- female: 100 %
- male: 0.0 %
Age of people who take Prednisone for Multiple sclerosis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 33.33 %
- 30-39: 33.33 %
- 40-49: 33.33 %
- 50-59: 0.0 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Prednisone?
- You can start a phase IV clinical trial to monitor Prednisone safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Prednisone (636,824 reports)
Treatments, associated drugs and conditions:
- Multiple sclerosis (799,636 reports)
How the study uses the data?
The study is based on prednisone (the active ingredients of Prednisone) and Prednisone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Methylprednisolone Acetate cause Sciatica? - 11 seconds ago
- Could Quinapril Hydrochloride cause Orthostatic Hypotension? - 17 seconds ago
- Fluid Retention and drugs of ingredients of candesartan cilexetil - 21 seconds ago
- Phenergan and Respiratory Arrest for Women aged 50-59 - 21 seconds ago
- Phenergan and Respiration Slowed Or Stopped for Women aged 50-59 - 21 seconds ago
- Phenergan and Not Breathing for Women aged 50-59 - 22 seconds ago
- Phenergan and Apnea for Women aged 50-59 - 22 seconds ago
- Phenergan and Breathing - Slowed Or Stopped for Women aged 50-59 - 22 seconds ago
- Cleocin vs. Ceftin, side effect and effectiveness comparison - 24 seconds ago
- Codeine, Aspirin, Apap Formula No. 2 vs. Methotrexate, side effect and effectiveness comparison - 24 seconds ago